Results 231 to 240 of about 10,155 (245)
Some of the next articles are maybe not open access.

Unilateral Lymphangioleiomyomatosis

Journal of Thoracic Imaging, 2005
Pulmonary involvement in tuberous sclerosis complex (TSC) resembles lymphangioleiomyomatosis (LAM) in its clinical, radiologic, and histopathological features. Typical high-resolution computed tomography (HRCT) findings are of bilateral thin-walled cysts symmetrically throughout both lungs, with associated increase in lung volumes.
Audrey Eleanor Therese, Wenaden   +1 more
openaire   +2 more sources

Lymphangioleiomyomatosis

Chest, 2008
Lymphangioleiomyomatosis (LAM) is a rare, cystic lung disease that is associated with mutations in tuberous sclerosis genes, renal angiomyolipomas, lymphatic spread, and remarkable female gender restriction. The clinical course of LAM is characterized by progressive dyspnea on exertion, recurrent pneumothorax, and chylous fluid collections.
openaire   +4 more sources

Chylothorax in Lymphangioleiomyomatosis*

Chest, 2003
Pulmonary lymphangioleiomyomatosis (LAM) is a rare, serious disorder characterized by proliferation of abnormal smooth-muscle cells and affects almost exclusively women of childbearing age. Optimal management of chylothorax, a well-recognized complication of LAM, in these patients has not been defined.
Susan D. Fisher   +4 more
openaire   +3 more sources

Pulmonary lymphangioleiomyomatosis

Pathology, 1994
This paper reports a case of a 50 yr old premenopausal woman with pulmonary lymphangioleiomyomatosis. This asymptomatic woman was found to have 'pulmonary nodules' on routine chest x-ray simulating metastatic lesions. The final diagnosis was possible after pathological examination of the lung biopsy specimens.
A, Firouz-Abadi, J P, Higgins
openaire   +2 more sources

Lymphangiogenesis in Lymphangioleiomyomatosis

American Journal of Surgical Pathology, 2004
Lymphangioleiomyomatosis (LAM) is characterized by the proliferation of abnormal smooth muscle cells (LAM cells) in the lungs, lymph nodes, and/or other organs. We examined lymphangiogenesis using immunohistochemistry for Flt-4 (VEGFR-3), a new specific marker for lymphatic endothelial cells, as well as the expression of vascular endothelial growth ...
Sanae Souma   +10 more
openaire   +2 more sources

Lymphangioleiomyomatosis: A review

European Journal of Internal Medicine, 2008
Lymphangioleiomyomatosis (LAM) is a rare disease, of unknown etiology, affecting women almost exclusively. Microscopically, LAM consists of a diffuse proliferation of smooth muscle cells. LAM can occur without evidence of other disease (sporadic LAM) or in conjunction with tuberous sclerosis complex (TSC).
Saman N Ratnayake   +3 more
openaire   +3 more sources

Living with lymphangioleiomyomatosis

BMJ, 2010
Since being diagnosed with lymphangioleiomyomatosis, Havi Carel has learnt much about the adaptability of the body and quality of life issues for patients with chronic ...
Havi Carel, Liz Gamble, Simon R. Johnson
openaire   +4 more sources

Current management of lymphangioleiomyomatosis

Current Opinion in Pulmonary Medicine, 2011
Lymphangioleiomyomatosis (LAM) is a rare but devastating disease, leading to chronic respiratory failure. Considerable progress for comprehension of the disease has been made when mutations of the tuberous sclerosis genes TSC1 and TSC2, were discovered in LAM cells.
Raphael Borie   +2 more
openaire   +3 more sources

Pleural Disease in Lymphangioleiomyomatosis

Clinics in Chest Medicine, 2006
Pleural disease is a common complication of lymphangioleiomyomatosis (LAM). The incidence and recurrence rates of secondary spontaneous pneumothorax in LAM are the highest among chronic pulmonary disorders. Most patients have at least one pneumothorax before LAM is diagnosed, and pneumothorax is often the sentinel event that leads to the diagnosis ...
Francis X. McCormack   +2 more
openaire   +3 more sources

Treatment of Lymphangioleiomyomatosis

New England Journal of Medicine, 1991
Lymphangioleiomyomatosis is a rare disease which afflicts young women of childbearing age. It is sufficiently uncommon that randomization or any other systematic evaluation of regimens of treatment has been difficult. Review of scattered case reports implies that a number of hormonal manipulations may be equally effective. A comprehensive review of the
Jay H. Ryu   +12 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy